Xi Wang
Cancer Research · with Khalil · 2018
A researcher in the Science corpus: 1 paper; trusts 7 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 23 citations into it
- Molecular Biology — 13 citations into it
- Oncology — 13 citations into it
- Hematology — 11 citations into it
- Genetics — 5 citations into it
Whom Xi Wang trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- S. Coughlin
- W. Nelson
- Zena Werb
- Gillian Murphy
- Hideaki Nagase
- A. Newby
- M. Pepper
- J. Folkman
- R. Nusse
- J. Roberts
Who trusts Xi Wang overall
Papers from Xi Wang's perspective
Ordered by how strongly the researchers Xi Wang trusts endorse each paper. Same corpus, a different order for every researcher.
- TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)*
- Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. (Journal of Clinical Investigation)
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations (Science)
- Structure and function of matrix metalloproteinases and TIMPs. (Cardiovascular Research)
- Matrix metalloproteinases and the regulation of tissue remodelling (Nature reviews. Molecular cell biology)
- PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. (Cell)
- Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. (Physiological Reviews)
- Metalloproteinase inhibitors: biological actions and therapeutic opportunities (Journal of Cell Science)
- Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. (Journal of Clinical Investigation)
- Progress in matrix metalloproteinase research. (Molecular Aspects of Medicine)
Their papers
- Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. (2018) — 586 citations